Danske Bank A/S (0NVC)
London Exchange · UK · prices in DKK · close of 23 Oct 2026
Key indicators
| Last close | DKK 339.60 |
|---|---|
| 52-week range | 269.00 – 386.20 |
| Return, 1 month / 3 months | −8.8% / −5.1% |
| Return, 1 year / 3 years | +29.1% / +151.3% |
| Trend | Below its 200-day average |
| RSI (14) | 26 |
| Volatility (1 year) | 19.2% |
| Worst drawdown (1 year) | -10.8% |
| Average daily value traded | 59.05M DKK |
| Dividend yield | 3.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Danske Bank is a Danish bank based in Copenhagen. It provides banking services to personal customers, businesses and institutional clients, including deposits, lending, mortgages, insurance and wealth management. Its home market is Denmark, and it also serves customers elsewhere in the Nordic region and in other international financial centres. The bank offers everyday accounts and payment services alongside financing and advisory services for companies and organisations.
On this site Danske Bank A/S appears as a stock on the London Exchange (UK), code 0NVC, with prices in Danish kroner (DKK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Danske Bank A/S (0NVC) trades on the London Exchange in UK. It last closed at DKK 339.60 on 23 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 397 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 29.1% and over the last three months it fell 5.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -0.1% | ||
| From 52-week high | -10.8% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -5.1% | ||
| 6-month return | 7.3% | ||
| 12-month return, skipping the last month | 41.6% | ||
| Stability (higher is calmer) | 91 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -10.8% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 59.05M DKK | ||
| Zero-volume days | 0.0% | ||
| Income | 50 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.5% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.3% |
|---|---|
| 1 month | −8.8% |
| 3 months | −5.1% |
| 6 months | +7.3% |
| 1 year | +29.1% |
| 3 years | +151.3% |
| 5 years | +269.6% |
Signals
| 50-day / 200-day average | 367.19 / 340.03 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 15.31 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 May 2026 | DKK 6.1400 |
| 27 Mar 2026 | DKK 5.7800 |
| 21 Mar 2025 | DKK 5.3500 |
| 9 Dec 2024 | DKK 6.5000 |
| 22 Jul 2024 | DKK 7.5000 |
| 22 Mar 2024 | DKK 7.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.